A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
Clinical trial NCT02374450 · COMPLETED
Trial details
- NCT number
- NCT02374450
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-10-05
- Primary completion
- 2022-08-02
- Enrollment
- 36366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.